CAS RN: 85700-46-5

5,7-Dihydroxy-2-(4-hydroxyphenyl)-6-((2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)-8-((2S,3R,4S,5S)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)-4H-chromen-4-one

Product Availability

Choose a grade to view its available package options.

3 package records0 with current stock2 grade groups
Batch No.PackageAvailabilityLead TimeInquiry
Batchno.20250306 5mg Out of stock 15 business days Inquiry
Batch No.PackageAvailabilityLead TimeInquiry
Batchno.20250816 1mg Out of stock Inquiry
Batchno.20250716 5mg Out of stock Inquiry
GET A QUOTE

85700-46-5 / 5,7-dihydroxy-2-(4-hydroxyphenyl)-6-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]-8-[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]chromen-4-one

Apigenin-6-C-|A-D-xylopyranosyl-8-C-|A-L-arabinopyranoside | APIGENIN-6-C-BETA-D-XYLOPYRANOSYL-8-C-ALPHA-L-ARABINOPYRANOSIDE | orb1941785

Standard CAS: 85700-46-5 Multi CAS: Yes

Basic Information

CAS
85700-46-5
Multi CAS
Yes
Molecular Formula
C25H26O13
Molecular Weight
534.500000
Exact Mass
534.137341
SMILES
C1C(C(C(C(O1)C2=C(C(=C3C(=C2O)C(=O)C=C(O3)C4=CC=C(C=C4)O)C5C(C(C(CO5)O)O)O)O)O)O)O
InChI
InChI=1S/C25H26O13/c26-9-3-1-8(2-4-9)13-5-10(27)14-19(32)15(24-21(34)17(30)11(28)6-36-24)20(33)16(23(14)38-13)25-22(35)18(31)12(29)7-37-25/h1-5,11-12,17-18,21-22,24-26,28-35H,6-7H2/t11-,12+,17+,18+,21-,22-,24+,25+/m1/s1
InChIKey
LDVNKZYMYPZDAI-MMIBADOTSA-N
Synonyms
Apigenin-6-C-|A-D-xylopyranosyl-8-C-|A-L-arabinopyranoside APIGENIN-6-C-BETA-D-XYLOPYRANOSYL-8-C-ALPHA-L-ARABINOPYRANOSIDE orb1941785 LMPK12110204 T82985

Computed Properties

Structural Parameters

Heavy atom count
38
Aromatic heavy atom count
16
Fraction Csp3
0.4
Rotatable bonds
3
H-bond acceptors
13
H-bond donors
9
Molar refractivity
126.34
TPSA
230.74

LogP / Solubility

WLOGP
-1.12
MLOGP
-0.94
XLogP3
-2.1
Consensus LogP
-1.39
Log S (ESOL)
-2.56
Class (ESOL)
Moderately soluble
Log S (Ali)
-3.14
Class (Ali)
Poorly soluble
Log S (SILICOS-IT)
-2.57
Class (SILICOS-IT)
Moderately soluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-6.77

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Leadlikeness
No
Synthetic Accessibility
9

Get In Touch

Contact Us